Tenofovir vs lamivudine plus adefovir in chronic hepatitis B: TENOSIMP-B study.

about

Tenofovir vs lamivudine plus adefovir in chronic hepatitis B: TENOSIMP-B study.

Item

http://www.wikidata.org/entity/Q47098116

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Tenofovir vs lamivudine plus adefovir in chronic hepatitis B: TENOSIMP-B study.

@en

Tenofovir vs lamivudine plus adefovir in chronic hepatitis B: TENOSIMP-B study.

@nl

type

Item

label

Tenofovir vs lamivudine plus adefovir in chronic hepatitis B: TENOSIMP-B study.

@en

Tenofovir vs lamivudine plus adefovir in chronic hepatitis B: TENOSIMP-B study.

@nl

prefLabel

Tenofovir vs lamivudine plus adefovir in chronic hepatitis B: TENOSIMP-B study.

@en

Tenofovir vs lamivudine plus adefovir in chronic hepatitis B: TENOSIMP-B study.

@nl

P1476

Tenofovir vs lamivudine plus adefovir in chronic hepatitis B: TENOSIMP-B study

@en

P2093

Enrique Fraga

http://www.w3.org/2001/XMLSchema#string

Esther Molina

http://www.w3.org/2001/XMLSchema#string

Francisco Jorquera

http://www.w3.org/2001/XMLSchema#string

Javier Fuentes

http://www.w3.org/2001/XMLSchema#string

Javier Salmerón

http://www.w3.org/2001/XMLSchema#string

José Antonio Pons

http://www.w3.org/2001/XMLSchema#string

José Luis Calleja

http://www.w3.org/2001/XMLSchema#string

José Manuel González

http://www.w3.org/2001/XMLSchema#string

Juan Manuel Pascasio

http://www.w3.org/2001/XMLSchema#string

Manuel Rodríguez

http://www.w3.org/2001/XMLSchema#string

P2860

Management of chronic hepatitis B before and after liver transplantation

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

Interpreting trial results following use of different intention-to-treat approaches for preventing attrition bias: a meta-epidemiological study protocol.

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study.

Lamivudine for patients with chronic hepatitis B and advanced liver disease.

Tenofovir disoproxil fumarate is superior to lamivudine plus adefovir in lamivudine-resistant chronic hepatitis B patients.

Cost of Treatment in HBeAg-Negative Chronic Hepatitis B Patients with 10-Years Projection Analysis

Hepatitis B e antigen-positive chronic hepatitis B: natural history and treatment.

Hepatitis B e antigen-negative chronic hepatitis B: natural history and treatment.

Tenofovir disoproxil fumarate (TDF) vs. emtricitabine (FTC)/TDF in lamivudine resistant hepatitis B: A 5-year randomised study.

P304

7459-7469

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V23.I41.7459

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Martin Prieto

G Sánchez-Antolín

P577

2017-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29151700

http://www.w3.org/2001/XMLSchema#string

P932

5685852

http://www.w3.org/2001/XMLSchema#string